Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 180,002 | 227,460 | 73,997 | 66,579 | 116,049 |
| Marketable Securities | 110,704 | 119,927 | 140,556 | 176,221 | 137,567 |
| Receivables | N/A | 1,250 | 1,251 | 2,604 | 9,387 |
| TOTAL | $303,628 | $358,811 | $224,555 | $251,978 | $268,777 |
| Non-Current Assets | |||||
| PPE Net | 17,938 | 17,355 | 15,047 | 13,580 | 13,897 |
| Investments And Advances | 1,896 | 7,938 | 17,029 | 31,149 | 51,225 |
| Other Non-Current Assets | 31,397 | 12,189 | 13,017 | 8,988 | 9,041 |
| TOTAL | $51,231 | $37,482 | $45,093 | $53,717 | $74,163 |
| Total Assets | $354,859 | $396,293 | $269,648 | $305,695 | $342,940 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,735 | 8,623 | 5,450 | 4,879 | 4,018 |
| Accrued Expenses | 45,094 | 48,900 | 18,913 | 13,153 | 14,226 |
| TOTAL | $82,258 | $94,591 | $56,165 | $47,863 | $46,415 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,643 | 16,117 | 19,036 | 21,872 | 24,639 |
| Deferred Revenues | 16,819 | 21,624 | 19,829 | 21,242 | 22,602 |
| Other Non-Current Liabilities | 29,453 | 20,434 | 14,947 | 9,971 | 11,564 |
| TOTAL | $141,094 | $125,964 | $112,417 | $114,127 | $121,775 |
| Total Liabilities | $223,352 | $220,555 | $168,582 | $161,990 | $168,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,601 | 4,592 | 4,586 | 4,581 | 4,577 |
| Common Shares | 92 | 92 | 92 | 92 | 91 |
| Retained earnings | -614,354 | -564,353 | -632,571 | -584,241 | -548,776 |
| Other shareholders' equity | -60 | 11 | 12 | -15 | -47 |
| TOTAL | $131,507 | $175,738 | $101,066 | $143,705 | $174,750 |
| Total Liabilities And Equity | $354,859 | $396,293 | $269,648 | $305,695 | $342,940 |